LRRK2, GBA and SMPD1 Founder Mutations and Parkinson's Disease in Ashkenazi Jews

Publisher： Karger

E-ISSN： 1421-9824|42|1-2|1-6

ISSN： 1420-8008

Source： Dementia and Geriatric Cognitive Disorders, Vol.42, Iss.1-2, 2016-07, pp. : 1-6

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Occurrence of PARK2 Mutations in a Never-Smoker Population with Parkinson’s Disease in North India

By  

Neuroepidemiology, Vol. 35, Iss. 2, 2010-06 ,pp. : 152-159

Karger

Access to resources Recommend Favorite

Lack of Evidence for an Association between Two Genetic Polymorphisms in the Tumor Necrosis Factor Receptor 1 Gene and Multiple Sclerosis in Ashkenazi Jews

By  

European Neurology, Vol. 46, Iss. 3, 2001-10 ,pp. : 153-155

Karger

Access to resources Recommend Favorite

Gene-Environment Interaction in Parkinson's Disease: Coffee, ADORA2A, and CYP1A2

By  

Neuroepidemiology, Vol. 47, Iss. 3-4, 2016-01 ,pp. : 192-200

Karger

Access to resources Recommend Favorite

PSMC1 Gene in Parkinson’s Disease

By  

European Neurology, Vol. 68, Iss. 4, 2012-08 ,pp. : 193-198

Karger

Access to resources Recommend Favorite

No Detected Mutations in the Genes for the Amyloid Precursor Protein and Presenilins 1 and 2 in a Swiss Early-Onset Alzheimer’s Disease Family with a Dominant Mode of Inheritance

By  

Dementia and Geriatric Cognitive Disorders, Vol. 10, Iss. 6, 1999-11 ,pp. : 431-436

Karger

Access to resources Recommend Favorite